Prevalence of psychiatric disorders among young injection drug users.

BACKGROUND Studies of individuals in treatment for substance use have found high rates of psychiatric disorders, however little is known about the mental health of drug users not in treatment. This study aimed to assess the prevalence of lifetime and recent substance use and psychiatric disorders among young injection drug users (IDU) outside of a treatment setting. METHODS Participants were recruited through outreach and respondent-driven sampling. Trained interviewers administered the Psychiatric Research Instrument for Substance and Mental Disorders. Interviews were conducted at two field stations operated by Community Outreach Intervention Projects in Chicago. Participants were 570 young adults (18-25 years) who injected drugs in the previous 30 days. Heroin was the primary drug used in this sample. Past 12-month and lifetime substance use disorders and primary and substance-induced mental disorders were based on DSM-IV diagnostic criteria. RESULTS Nearly all participants met the criteria for heroin dependence. Multiple substance use disorders were common; cannabis was the most common substance involved after heroin, followed by alcohol and cocaine. Major depression, alcohol dependence, antisocial personality disorder, and borderline personality disorder were highly prevalent. Other psychiatric disorders were observed at levels consistent with other young adult samples. CONCLUSIONS Young IDU experience major depression, alcohol dependence, anti-social personality disorder, and borderline personality disorder at high rates, and multiple substance use disorders are common. Anxiety disorders in this population appear to be similar in prevalence to young adults in general.

[1]  M. Fendrich,et al.  Decreased drug reporting in a cross-sectional student drug use survey. , 2000, Journal of substance abuse.

[2]  E. Liebau,et al.  RDS - a Stata program for respondent-driven sampling , 2010 .

[3]  M. Torrens,et al.  Psychiatric comorbidity in young heroin users. , 2006, Drug and alcohol dependence.

[4]  M M Weissman,et al.  Lifetime prevalence of specific psychiatric disorders in three sites. , 1984, Archives of general psychiatry.

[5]  R. Brooner,et al.  Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. , 2004, Drug and alcohol dependence.

[6]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[7]  M. Lynskey,et al.  Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. , 2005, Drug and alcohol dependence.

[8]  J. Sweeney,et al.  Psychiatric comorbidity in methadone maintained patients. , 1998, Journal of addictive diseases.

[9]  J. Talbott,et al.  Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions , 2006 .

[10]  K. Mills,et al.  Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). , 2004, Journal of substance abuse treatment.

[11]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[12]  R. Drake,et al.  Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. , 2005, Archives of general psychiatry.

[13]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[14]  Stacey B. Daughters,et al.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. , 2011, Drug and alcohol dependence.

[15]  V. Warner,et al.  Symptom and substance use reporting consistency over two years for offspring at high and low risk for depression , 1994, Journal of abnormal child psychology.

[16]  M. Olfson,et al.  Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. , 2008, Archives of general psychiatry.

[17]  I. Crome,et al.  Co-existing Problems of Mental Health and Substance Misuse (Dual Diagnosis): a literature review , 2003 .

[18]  J. Gorman,et al.  Psychopathology in male and female HIV‐positive and negative injecting drug users: longitudinal course over 3 years , 1997, AIDS.

[19]  S. Dinwiddie.  Characteristics of injection drug users derived from a large family study of alcoholism. , 1997, Comprehensive psychiatry.

[20]  Douglas D. Heckathorn,et al.  Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hi , 2002 .

[21]  L. Thorpe,et al.  Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). , 2001 .

[22]  L. Ouellet,et al.  Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. , 2008, Drug and alcohol dependence.

[23]  R. Baldessarini,et al.  Suicide attempts in major affective disorder patients with comorbid substance use disorders. , 1999, The Journal of clinical psychiatry.

[24]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[25]  R. Kessler,et al.  Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[26]  T. Trauer,et al.  Prevalence of Psychiatric Disorder in a Methadone Maintenance Population , 2001, The Australian and New Zealand journal of psychiatry.

[27]  R. Kessler,et al.  DSM-IV Personality Disorders in the National Comorbidity Survey Replication , 2007, Biological Psychiatry.

[28]  D. D. Jarlais,et al.  The first and second decades of AIDS among injecting drug users. , 1992 .

[29]  B. Grant,et al.  The 12-Month Prevalence and Trends in DSM–IV Alcohol Abuse and Dependence , 2004, Drug and alcohol dependence.

[30]  D. Heckathorn.  6. Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment , 2007 .

[31]  K. Brady,et al.  Posttraumatic stress disorder and cocaine dependence. Order of onset. , 1998, The American journal on addictions.

[32]  Matthias Schonlau,et al.  Respondent-Driven Sampling , 2010 .

[33]  L B Cottler,et al.  Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. , 2000, The American journal on addictions.

[34]  H. Siegal,et al.  Introduction: Health Services Research Among Drug Abusers , 1998 .

[35]  S. Darke,et al.  Polydrug dependence and psychiatric comorbidity among heroin injectors. , 1997, Drug and alcohol dependence.

[36]  M. Stein,et al.  Depression among needle exchange program and methadone maintenance clients. , 2000, Journal of substance abuse treatment.

[37]  R. Brooner,et al.  Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.

[38]  D. Heckathorn,et al.  Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.

[39]  S. Southwick,et al.  Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. , 1996, The American journal of psychiatry.

[40]  S. Darke,et al.  Antisocial personality disorder, psychopathy and injecting heroin use. , 1998, Drug and alcohol dependence.

[41]  C. Bench,et al.  Comorbidity of substance misuse and mental illness in community mental health and substance misuse services , 2003, British Journal of Psychiatry.

[42]  L. Thorpe,et al.  Injection‐Related Risk Behaviors in Young Urban and Suburban Injection Drug Users in Chicago (1997‐1999) , 2001, Journal of acquired immune deficiency syndromes.

[43]  R. Kessler.  The epidemiology of dual diagnosis , 2004, Biological Psychiatry.

[44]  J. Endicott,et al.  Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. , 1996, The American journal of psychiatry.

[45]  K. Brady,et al.  Current review of the comorbidity of affective, anxiety, and substance use disorders , 2003 .

[46]  Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. , 2006 .

[47]  J. Alvidrez,et al.  Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. , 2004, The American journal of psychiatry.

[48]  R. Craig,et al.  MCMI-III-derived typological analysis of cocaine and heroin addicts. , 1997, Journal of personality assessment.

[49]  B. Grant,et al.  Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2004, The Journal of clinical psychiatry.

[50]  E. Nunes,et al.  Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. , 2006, The American journal of psychiatry.

[51]  G. Woody,et al.  Psychiatric comorbidity: prevalence in methadone maintenance treatment. , 1996, The American journal of drug and alcohol abuse.

[52]  W. Hall,et al.  Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. , 1994, Addiction.